Ding Xue

Ding Xue

Auto-generated profile, based on publicly available information

Ding Xue

Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
SSSoma Samanta
Soma Samanta
Suhui YangSuhui Yang
Suhui Yang
BDBikash Debnath
Bikash Debnath
DXDing Xue
Ding Xue
YKYuting Kuang
Yuting Kuang
NNNouri Neamati
Nouri Neamati
GRP78 (glucose-regulated protein, 78 kDa) is a key regulator of endoplasmic reticulum (ER) stress signaling. Cancer cells are highly proliferative and have high demand for protein synthesis and folding, which results in significant stress on the ER. To respond to ER stress and maintain cellular homeostasis, cells activate the unfolded protein response (UPR) that promotes either survival or apoptotic death. Cancer cells utilize the UPR to promote survival and growth. In this study, we describe the discovery of a series of novel hydroxyquinoline GRP78 inhibitors. A representative analogue, YUM70, inhibited pancreatic cancer cell growth in vitro and showed in vivo efficacy in a pancreatic cancer xenograft model with no toxicity to normal tissues. YUM70 directly bound GRP78 and inactivated its function, resulting in ER stress–mediated apoptosis. A YUM70 analogue conjugated with BODIPY showed colocalization of the compound with GRP78 in the ER. Moreover, a YUM70-PROTAC (proteolysis targeting chimera) was synthesized to force degradation of GRP78 in pancreatic cancer cells. YUM70 showed a strong synergistic cytotoxicity with topotecan and vorinostat. Together, our study demonstrates that YUM70 is a novel inducer of ER stress, with preclinical efficacy as a monotherapy or in combination with topoisomerase and HDAC inhibitors in pancreatic cancer. Significance: This study identifies a novel ER stress inducer that binds GRP78 and inhibits pancreatic cancer cell growth in vitro and in vivo, demonstrating its potential as a therapeutic agent for pancreatic cancer.

15 February 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DXDing Xue
Ding Xue
YXYibin Xu
Yibin Xu
AKArmita Kyani
Armita Kyani
JRJoyeeta Roy
Joyeeta Roy
LDLipeng Dai
Lipeng Dai
NNNouri Neamati
Nouri Neamati

4 January 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DXDing Xue
Ding Xue
YXYibin Xu
Yibin Xu
AKArmita Kyani
Armita Kyani
JRJoyeeta Roy
Joyeeta Roy
LDLipeng Dai
Lipeng Dai
NNNouri Neamati
Nouri Neamati

28 June 2023 in ACS Pharmacology & Translational Science
Verified
Journal Article
Closed access
YXYibin Xu
Yibin Xu
DXDing Xue
Ding Xue
AKArmita Kyani
Armita Kyani
ABArmand Bankhead
Armand Bankhead
JRJoyeeta Roy
Joyeeta Roy
NNNouri Neamati
Nouri Neamati

31 March 2023
Verified
Other
Open access
SSSoma Samanta
Soma Samanta
Suhui YangSuhui Yang
Suhui Yang
BDBikash Debnath
Bikash Debnath
DXDing Xue
Ding Xue
YKYuting Kuang
Yuting Kuang
NNNouri Neamati
Nouri Neamati
GRP78 (glucose-regulated protein, 78 kDa) is a key regulator of endoplasmic reticulum (ER) stress signaling. Cancer cells are highly proliferative and have high demand for protein synthesis and folding, which results in significant stress on the ER. To respond to ER stress and maintain cellular homeostasis, cells activate the unfolded protein response (UPR) that promotes either survival or apoptotic death. Cancer cells utilize the UPR to promote survival and growth. In this study, we describe the discovery of a series of novel hydroxyquinoline GRP78 inhibitors. A representative analogue, YUM70, inhibited pancreatic cancer cell growth in vitro and showed in vivo efficacy in a pancreatic cancer xenograft model with no toxicity to normal tissues. YUM70 directly bound GRP78 and inactivated its function, resulting in ER stress–mediated apoptosis. A YUM70 analogue conjugated with BODIPY showed colocalization of the compound with GRP78 in the ER. Moreover, a YUM70-PROTAC (proteolysis targeting chimera) was synthesized to force degradation of GRP78 in pancreatic cancer cells. YUM70 showed a strong synergistic cytotoxicity with topotecan and vorinostat. Together, our study demonstrates that YUM70 is a novel inducer of ER stress, with preclinical efficacy as a monotherapy or in combination with topoisomerase and HDAC inhibitors in pancreatic cancer.Significance:This study identifies a novel ER stress inducer that binds GRP78 and inhibits pancreatic cancer cell growth in vitro and in vivo, demonstrating its potential as a therapeutic agent for pancreatic cancer.

31 March 2023
Verified
Other
Open access
SSSoma Samanta
Soma Samanta
Suhui YangSuhui Yang
Suhui Yang
BDBikash Debnath
Bikash Debnath
DXDing Xue
Ding Xue
YKYuting Kuang
Yuting Kuang
NNNouri Neamati
Nouri Neamati
Supplementary materials include detailed chemistry, supplementary materials and methods, references, and supplementary figures.